Buy Naprocap 500mg Capecitabine

Naprocap 500mg is an oral chemotherapy tablet containing capecitabine, used for cancer treatment. This 500mg strength medication supports chemotherapy regimens in a 10-tablet pack. Suitable for ambient storage, it is prescribed under medical supervision for targeted therapy.

Strength

500mg

Pack Size

10s

Storage

Ambient

Manufacturer / TM Owner

Naprod Life Sciences Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Naprocap 500mg (capecitabine) is used to treat certain types of cancer, including colorectal and breast cancer. It works by interfering with cancer cell growth, often as part of a combination therapy. Patients may take this medication to manage advanced or metastatic cancer under physician guidance. It is not intended for self-treatment without professional oversight.

Side Effects

Naprocap 500mg may cause mild to moderate side effects such as nausea, fatigue, or hand-foot syndrome. Some users report digestive discomfort or changes in taste. These effects vary by individual and are typically monitored during treatment. Hydration and rest can help manage common reactions.

Precautions & Warnings

Keep Naprocap 500mg in a cool, dry place away from direct sunlight. Avoid crushing or splitting tablets unless directed by a healthcare provider. Inform your doctor about all medications and conditions before starting treatment. Pregnant or breastfeeding individuals should consult a physician before use.

Avoid Interactions

Naprocap 500mg may interact with blood thinners, certain antibiotics, or other chemotherapy drugs. Alcohol and grapefruit products can amplify side effects. Always disclose all prescriptions and supplements to your healthcare team. CYP2C9 inhibitors may alter capecitabine metabolism, requiring dose adjustments.

References

Frequently Asked Questions

Naprocap 500mg is used to treat certain cancers, including colorectal and breast cancer, as part of a chemotherapy regimen.

Store Naprocap 500mg at ambient temperature in a dry, cool place away from direct light and moisture.

Consult your doctor before combining Naprocap 500mg with other drugs, as interactions may occur.

Common side effects include nausea, fatigue, and hand-foot syndrome, which vary by individual.

Pregnant individuals should discuss risks with a healthcare provider before using Naprocap 500mg.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.